Please assess the completion status of the following clinical trial:

Trial Title: A Trial of Daily Ultraviolet Therapy to Reduce Cardiovascular Risk Factors

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Pre-hypertensives (BP 120-139/80-89).~* Fitzpatrick skin types 2 and above (i.e. the ability to tan)~Exclusion Criteria:~* History of skin cancer.~* Fitzpatrick type 1 skin (always burns, never tans).~* Red hair.~* Family history of melanoma in first degree relative.~* Atypical naevus syndrome.~* Planned holiday or foreign travel during and for 4 weeks before the period of the study.~* Concurrent administration of:~  * anti-hypertensive medication,~ * photosensitising medication,~ * systemic immunosuppressive medication.

- Gender: ALL
- Minimum Age: 16 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Active (Type: EXPERIMENTAL): UVA irradiation.
- Sham UVA irradiation (Type: SHAM_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).